Humana Cumulative Cost Basis increased by 9.2% to $18.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.3%, from $19.43B to $18.59B. Over 3 years (FY 2022 to FY 2025), Cumulative Cost Basis shows relatively stable performance with a 2.2% CAGR.
Provides a baseline for understanding the scale of the bank's investment and lending activities over time.
The total historical cost of assets or liabilities before any accounting adjustments for fair value, impairment, or amor...
Standard accounting disclosure for financial assets and liabilities.
cumulative_cost_basis| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.95B | $16.75B | $17.23B | $18.30B | $18.49B | $19.27B | $20.28B | $20.02B | $19.43B | $19.11B | $18.04B | $17.02B | $18.59B |
| QoQ Change | — | +5.0% | +2.9% | +6.2% | +1.0% | +4.2% | +5.3% | -1.3% | -3.0% | -1.6% | -5.6% | -5.7% | +9.2% |
| YoY Change | — | — | — | +14.8% | +10.4% | +11.8% | — | +9.4% | +5.1% | -0.8% | -11.0% | -15.0% | -4.3% |